Innovations Theater Presentation Will Highlight Exceptional Results of Gentrix Surgical Matrix in Ventral Hernia Repair
Columbia, MD—(October 22, 2018) – ACell, Inc. today announced their participation in the 2018 American College of Surgeons (ACS) Clinical Congress being held October 22-25 in Boston, Massachusetts.
ACell will sponsor an Innovations Theater presentation titled “Shifting the Paradigm : A New Approach to Ventral Hernia Repair,” on October 24 at 12 noon. This program will provide an overview of clinical and pre-clinical research detailing the remodeling response of ACell’s Gentrix® Surgical Matrix devices and their ability to facilitate the deposition of biomechanically functional tissue. The event will be led by Collin Brathwaite, MD, Chairman of Surgery at NYU Winthrop Hospital.
Hands-on product demonstrations and additional product information will be available at ACell’s booth, located in the exhibit hall at space #1035. ACell’s booth will feature devices for complex wound management, hernia repair, and open abdomen management.
“ACell is proud to support the ACS Clinical Congress and to highlight our Gentrix devices at the meeting’s Innovation Theater,” said Patrick McBrayer, President & CEO. “The series of recently published papers detailing results of our biologically-derived devices in ventral hernia repair has been very well received in the field, and we look forward to more people learning about how our products may offer a solution for surgeons treating complex abdominal wall reconstruction cases.”
About ACell, Inc.
ACell, Inc. is a leading regenerative medicine company focused on the development, manufacturing, and commercialization of medical devices for wound management and surgical soft tissue repair. ACell is committed to becoming and remaining an innovative leader in regenerative medical technology, offering superior healing options for doctors and patients. ACell is a privately held company and operates manufacturing facilities in Columbia, MD and Lafayette, IN.